This record was last updated June 15, 2025 (before its estimated November 14, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Lishui, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.
Protocol Amendment History
4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-21; most recent amendment 2025-06-10.